Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Cellular Stress Responses

Background:

• Lung cancer therapies remain largely unsatisfactory, necessitating novel treatment strategies.
• Oxidative and glycative stress synergize to form glycoxidation, a process implicated in lung cancer development.
• Key signaling pathways like p38 MAPK, NF-κB, and TNF-α are involved in lung cancer cell growth and metastasis.

Purpose of the Study:

• To elucidate the role of glycoxidation in lung cancer pathogenesis.
• To map signaling pathways modulated by glycoxidative products, including reactive dicarbonyls and advanced glycation end products (AGEs).
• To investigate the critical role of AGE-RAGE binding in regulating lung cancer progression.

Main Methods:

• Review of existing literature on oxidative stress, glycative stress, and glycoxidation in lung cancer.
• Analysis of signaling pathways involved in cell growth, proliferation, apoptosis inhibition, and metastasis.
• Examination of the AGE-RAGE binding interaction and its downstream effects on cancer signaling.

Main Results:

• Glycoxidation, driven by reactive dicarbonyls and AGEs, significantly influences lung cancer.
• AGE-RAGE binding critically regulates lung cancer suppression and promotion through diverse signaling pathways.
• Specific pathways including p38 MAPK, NF-κB, and TNF-α are identified as key players mediated by glycoxidation.

Conclusions:

• Oxidation, glycation, and glycoxidation are integral to lung cancer development and progression.
• Targeting AGE-RAGE interactions and associated signaling pathways presents a promising therapeutic avenue for lung cancer.
• A deeper understanding of glycoxidation-mediated signaling offers new insights for effective lung cancer treatment strategies.